ACIST CVi Value System Brochure

This document explores the impact the ACIST CVi® Contrast Delivery System has in reducing angiography complications and cost while delivering value. CVi® can be beneficial in enhancing patient safety, improving workplace safety, and boosting operational efficiency. By reading this document, you will gain insights into the benefits offered by CVi®.

 

Increasing Patient Safety: Statistics: up to 30% reduction in CI-AKI vs. manual injection. Around a 25% reduction in contrast use without compromising image quality when comparing 4FR to 6FR diagnostic procedures.

Increasing Workplace Safety: Up to 50% reduction in clinician radiation exposure by stepping back. 49.4% of interventional cardiologists have experienced at least one orthopedic injury.8

Increasing Operational Efficiency: 45mL decrease per case when injector used. An average of 5 minutes faster per procedure.

 

Note: See full resource above for complete citations and references.

Dr Bob Wilson Study – Radiation Scatter in the Cath Lab

Dr. Wilson, Interventional Cardiologist and founder of ACIST Medical Systems, discusses the importance of minimizing radiation scatter within the catheterization lab. Until recently, little was known about the specific risks that cath lab professionals could encounter due to radiation exposure and what this means for workplace and provider safety. Consequently, Dr. Wilson and his team have chosen to maintain thorough records of radiation measurements in cath labs to better analyze radiation scatter and its effects on individuals in the cath lab.

 

“We got to reduce the occupational exposure for radiation for people working in cath labs, because they are really in a sense guinea pigs right now. They are the only people of any profession that are getting this kind of radiation every day. And it takes 30 years to know what happens and its been 30 years, and we know what happens isn’t good. So we decided that we were going to start making detailed measurements for radiation around the table.” – Dr. Wilson

 

Note: See full resource above for complete citations and references.

 

PSI vs Flow Rate with CVi

Dr. Wilson, Interventional Cardiologist and founder of ACIST Medical Systems, explains the distinguishing features of the ACIST CVi® Contrast Delivery System compared to other injection systems. One notable difference is that ACIST CVi® utilizes longer tubing, which facilitates more pressure dissipation along its length. It is important to note that all pressure injectors have a flow rate limit, which depends on the catheter’s size. ACIST CVi® displays this information on the monitor, enhancing the ability to maintain appropriate pressure and flow rate levels.

 

“Oftentimes there is a very long tubing system within the ACIST System that allows you to get further form the table and get your catheter and all that business. So, with that longer tubing setting you can have more pressure dissipation across the tubing.” – Dr. Wilson

 

Note: See full resource above for complete citations and references.

COVID-19 Patient Care

ACIST Medical Systems offers diagnostic tools to enhance patient care. Education is a key aspect of our partnership. Clinical evidence highlights the impact of COVID-19 on multiple organs, including the kidneys. Acute kidney injury (AKI) can occur in not just the elderly, but also young and healthy adults with COVID-19. A strong correlation exists between cardiac and kidney injury in COVID-19 patients. AKI is associated with severity and mortality, affecting up to 30% of hospitalized patients. Post-COVID-19 recovery increases the risk of developing chronic kidney disease as well. ACIST CVi™ Contrast Delivery System mitigates the risk of CI-AKI during coronary angiography by reducing contrast dose and preserving renal function. It aligns with SCAI/ACC/AMA guidelines and demonstrates a 22% reduction in contrast delivered compared to the hand manifold. Read to learn more about our solution for optimizing patient care.

 

Note: See full resource above for complete citations and references.

CVi Consumables Sheet

The ACIST CVi® Contrast Delivery System offers a range of consumable products that aim to simplify setup, effectively manage contrast usage, and ensure precise control and consistency in delivering contrast during angiographic procedures. Among these consumables, you will find the AngioTouch® Hand Controller sets with either ATP or ATX patient kits, both intended for single-patient use. In contrast, the Multi-Use Syringe is suitable for up to 5 patient cases, while the Single-Use Automated Manifold and Pressure Monitoring Kit are designed for single-patient use. To get more specific product information, please continue reading this document.

 

Note: See full resource above for complete citations and references.

CVi Quick Guide

This is a quick guide for learning how to use and implement the ACIST CVi® Contrast Delivery System. There are a variety of components that make up the CVi® Contrast Injector. Some of these include touch screen monitor, saline pump, injector head, mobile cart, among others. Some of the consumables include the patient tubing, hand controller, multi-use syringe product, automated manifold product, and hand controller product. The document breaks into steps how to correctly load contrast, load saline tubing assembly, and purge and flush the tubing. It also expands on the setup of the AngioTouch® Hand Controller and how to perform an injection. Some important activities occur between cases or setups. These include between case activities, following the multi-use syringe procedure, as well as syringe removal and shut down. Lastly CVi® will display any alert messages on the monitor including air column detection, empty contrast, hand controller failure, along with more. Continue reading to learn more about the ACIST CVi® Contrast Delivery System, its parts, set-up, and use, as well as any troubleshooting if need be.

 

Note: See full resource above for complete citations and references.

Making the Case for CI-AKI Prevention With the ACIST CVi™ Contrast Delivery System

In this article by Dr. Sandeep Krishnan, Interventional and Structural Cardiologist at King’s Daughters Medical Center in Ashland, KY, we look at how the ACIST CVi® Contrast Delivery System can benefit medical professionals’ practices and their catheterization labs. CVi® has many safety features that can help reduce the risk of air injection. Not only does the CVi® System have various beneficial safety features, but it is seen by Dr. Krishnan as having a simpler and quicker setup than the traditional hand manifold. It is important to know that CVi® works on coronary cases as well as peripheral and structural procedures. Dr. Krishnan goes on to answer more questions regarding controlling contrast injection, usability of large-volume injections, and support for doing a peripheral runoff. Furthermore, he expands on how often contrast needs to be filled, how it reduces contrast use, along with backing the investment. Continue reading to learn more about the CVi® Contrast Delivery System, its uses, and benefits.

 

Note: See full resource above for complete citations and references.

ACIST CVi Contrast Delivery System

The ACIST CVi® Contrast Delivery System streamlines procedures, enhances patient care, optimizes workflow, and improves overall efficiency. It effectively caters to a wide range of angiographic procedures, accommodating both small injections in coronary arteries and large volumes in ventricles and peripheral vasculature. A key component of the system is the AngioTouch® Hand Controller, which enables real-time control of contrast injection rate, ensuring precise and consistent administration of contrast. The implementation of CVi® has yielded various benefits, including a notable 30% reduction in contrast-induced acute kidney injury (CI-AKI) and a 25% reduction in contrast usage compared to manual injection. Moreover, CVi® contributes to workplace safety by reducing clinician radiation exposure by 50% through step-back capabilities using the hand controller, while its design minimizes the risk of repetitive stress injuries for operators. In addition to these advantages, the system enhances operational efficiency by reducing contrast usage by 45 mL compared to manual injectors. It also saves an average of 5 minutes per procedure.

 

Increasing Patient Safety: up to 30% reduction in CI-AKI vs. manual injection. Around a 25% reduction in contrast use without compromising image quality when comparing 4FR to 6FR diagnostic procedures.

Increasing Workplace Safety: Up to 50% reduction in clinician radiation exposure by stepping back. 49.4% of interventional cardiologists have experienced at least one orthopedic industry.

Increasing Operational Efficiency: 45mL decrease per case when injector used. An average of 5 minutes faster per procedure.

 

Note: See full resource above for complete citations and references.

ACIST AT X65

One component of the ACIST CVi® Contrast Delivery System is the improved AngioTouch® Kit known as the ACIST AT X65. With AT X65, you may achieve a higher level of definition in the hemodynamic signal, enabling the dicrotic notch to be observed with greater clarity. The ACIST AT X65 features a dual rotator mechanism that minimizes torque, thereby enhancing the operator’s control over the catheter. Additionally, this kit offers a longer shelf life of 2 years, contributing to improved inventory management.

Note: See full resource above for complete citations and references.

ACIST CVi Knowledge Leadership

Discover the insights of Dr. Mark Rothenberg, Medical Director at Cardiac Catheterization Laboratory JFK Medical Center in West Palm Beach, FL, regarding the ACIST CVi™ Contrast Delivery System. Dr. Rothenberg has dedicated over two decades to his career in interventional cardiology, where he recognized the significance of efficient contrast delivery. Delve into the details of Dr. Rothenberg’s background and gain an understanding of his rationale for choosing the CVi® system.

 

Background: Contrast delivery has been an important concern for Dr. Rothenberg since he began his interventional cardiology career over 20 years ago. Throughout his practice many of his patients have been elderly with compromised renal function – this at greater risk for CI-AKI. As a proctor for transcatheter aortic valve replacement (TAVR). DR. Rothenberg is also keenly interested in anything that helps advance this alternative to open heart surgery. We asked Dr. Rothenberg for his insights on the value ACIST CVi® brings to his patients, clinicians, and hospital systems.

 

Note: See full resource above for complete citations and references.
Skip to content